Literature DB >> 8610584

Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries.

G A Holland1, L Dougherty, J P Carpenter, M A Golden, M Gilfeather, F Slossman, M D Schnall, L Axel.   

Abstract

OBJECTIVES: The objectives of this study were to develop and show the efficacy of a breath-hold ultrafast three-dimensional (3D) spoiled gradient-echo (SPGR) gadolinium-enhanced MR angiographic technique for imaging the aorta and the renal and other visceral arteries of the abdomen; and to compare breath-hold ultrafast 3D SPGR with two-dimensional (2D) time-of-flight (TOF) and non-breath-hold ultrafast 3D SPGR in the same patients. SUBJECTS AND METHODS: We prospectively studied the abdominal aorta and the renal and other visceral arteries 68 times in 63 consecutive patients with 2D TOF and ultrafast 3D SPGR MR angiography. Thirty-two patients had contrast angiography (n = 23) and/or surgery (n = 24) to serve as a gold standard. All MR imaging studies were performed on a 1.5-T scanner (General Electric Medical Systems, Milwaukee, WI) using an enhanced gradient system with maximum gradient strength of 2.3 gauss/cm reached in 150 microseconds. Axial 2D TOF parameters were: TR/TE, 33/5.5 msec; flip angle, 45 degrees; slice thickness, 2 mm; and no presaturation pulses. Coronal ultrafast 3D SPGR was performed before and after the i.v. administration of 40-60 cc of gadolinium. For the coronal ultrafast 3D SPGR, our parameters were: TR/TE, 4.8-7/1.1; flip angle, 60 degrees; 28-50 slices of 2.0-2.6 mm thickness; and acquisition time, 18-32 sec. Studies were read by a single radiologist [corrected] and were evaluated for the degree of stenosis in the renal, celiac, superior mesenteric, and inferior mesenteric arteries; any vascular anomalies (i.e., retroaortic renal veins and accessory renal or variant hepatic arteries) were noted.
RESULTS: Breath-hold ultrafast 3D SPGR correctly identified 31 of 31 stenoses of the renal artery for a sensitivity, specificity, and accuracy of 100%. Two-dimensional TOF detected 23 of 31 renal artery stenoses for a sensitivity, specificity, and accuracy of 74%, 98%, and 87% respectively. Breath-hold ultrafast 3D SPGR underestimated two renal arteries as having severe osteal stenoses that were graded correctly by 2D TOF and by angiography as occlusions. Eight of nine (89%) accessory renal arteries were correctly identified with breath-hold ultrafast 3D SPGR: Two-dimensional TOF identified six of nine (67%). Breath-hold ultrafast 3D SPGR identified one accessory and two reconstituted renal arteries missed by 2D TOF and conventional contrast angiography that were confirmed at surgery. Ultrafast 3D SPGR and 2D TOF correctly identified 20 of 20 celiac, superior mesenteric, and inferior mesenteric artery osteal stenoses or occlusions for a sensitivity, specificity, and accuracy of 100%. Three Riolan's arcs were correctly identified by breath-hold 3D SPGR but were missed by 2D TOF: Forty of the 63 patients did not have conventional contrast angiography and were managed surgically (n = 9) or medically (n = 31) based on the results of the MR angiograms and clinical data. Breath-hold ultrafast 3D SPGR MR angiography correctly identified and graded 48 of 51 renal, celiac, superior mesenteric, and inferior mesenteric artery stenoses or occlusions. Two-dimensional TOF MR angiography correctly identified and graded 45 of 51 renal, celiac, superior mesenteric, and inferior mesenteric artery stenoses and occlusions.
CONCLUSION: Breath-hold ultrafast 3D SPGR when combined with 2D TOF accurately identified and graded all (51 of 51) renal, celiac, superior mesenteric, and inferior mesenteric artery stenoses or occlusions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610584     DOI: 10.2214/ajr.166.4.8610584

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  3D contrast-enhanced MR angiography using fluoroscopic triggering and an elliptical centric view order.

Authors:  S J Riederer; S B Fain; D G Kruger; R F Busse
Journal:  Int J Card Imaging       Date:  1999-04

2.  Contrast enhanced body magnetic resonance angiography.

Authors:  A E Stillman
Journal:  Int J Card Imaging       Date:  1999-04

3.  Real-time imaging and triggering of 3D contrast-enhanced MR angiograms using MR fluoroscopy.

Authors:  S J Riederer; S B Fain; D G Kruger; R F Busse
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

Review 4.  Current concepts in the evaluation of vascular disease: magnetic resonance and computed tomographic angiography.

Authors:  B D Toombs; J M Jing
Journal:  Tex Heart Inst J       Date:  2000

Review 5.  An evidence-based approach to diagnosing renovascular hypertension.

Authors:  M J Bloch
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

6.  Contrast-enhanced MR angiography of the carotid and vertebrobasilar circulations.

Authors:  Carina W Yang; James C Carr; Stephen F Futterer; Mark D Morasch; Benson P Yang; Stephanie M Shors; J Paul Finn
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

7.  The optimization of scan timing for contrast-enhanced magnetic resonance angiography.

Authors:  J J Lee; P J Tirman; Y Chang; H K Ryeom; S K Lee; Y S Kim; D S Kang
Journal:  Korean J Radiol       Date:  2000 Jul-Sep       Impact factor: 3.500

8.  Contrast-enhanced magnetic resonance angiography: dose the test dose bolus represent the main dose bolus accurately?

Authors:  J J Lee; Y Chang; D S Kang
Journal:  Korean J Radiol       Date:  2000 Apr-Jun       Impact factor: 3.500

9.  MRI for detection of anomalous pulmonary venous drainage in patients with sinus venosus atrial septal defects.

Authors:  Maria Prompona; Olaf Muehling; Michael Naebauer; Stefan O Schoenberg; Maximilian Reiser; Armin Huber
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-05       Impact factor: 2.357

10.  Haemorrhagic complications of pancreatitis: presentation, diagnosis and management.

Authors:  B J Ammori; M Madan; D J Alexander
Journal:  Ann R Coll Surg Engl       Date:  1998-09       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.